So They Say

So They Say "It's like moving on from a first attempt demo music tape to a classic CD." --Jane Rogers, head of sequencing at the Wellcome Trust Sanger Institute, on the completed, full sequence, human genome. From MSNBC. "If Heimlich is really doing this, he should be put in jail." --Mark Harrington, executive director of AIDS activist group Treatment Action Network, on the plans of 83-year-old Henry Heimlich (of Heimlich Maneuver fame) to infect African AIDS patients with malaria to kill

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"It's like moving on from a first attempt demo music tape to a classic CD."

--Jane Rogers, head of sequencing at the Wellcome Trust Sanger Institute, on the completed, full sequence, human genome. From MSNBC.

"If Heimlich is really doing this, he should be put in jail."

--Mark Harrington, executive director of AIDS activist group Treatment Action Network, on the plans of 83-year-old Henry Heimlich (of Heimlich Maneuver fame) to infect African AIDS patients with malaria to kill the AIDS virus. From Reuters.

"I spoke about what my grandparents would have thought. And [then] Yogi goes up, he was in tears, and said, "Only thing I gotta say is, 'I'm glad that they didn't miss the boat.'"

--NIAID director Anthony Fauci describing speeches given by himself and baseball legend Yogi Berra at a recent Ellis Island awards ceremony. From The Scientist.

"Numbers of the cases have been declining continuously since ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies